Skip to main content

Table 4 Continuation of the miRNA expression and prognostic factors of ccRCC

From: Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics

  miR-200b miR-106a miR-106b
Low (n = 18) 43.39(89.17) 65.14(65.16) 159.44(171.94)
Intermediate (n = 29) 58.51(98.63) 110.15(141.57) 90.68(85.67)
High n = 9 563.01(1128.21) 202.94(270.20) 123.81(100.46)
P 0.01 b 0.23b 0.31b
Size ≥7 cm (n = 30) 57.91(97.01) 79.23(68.51) 125.34(140.61)
Size <7 cm (n = 26) 162.81(545.59) 139.51(196.72) 102.81(92.03)
P 0.36a 0.766 0.58a
MVI absent (n = 44) 55.97(95.09) 93.38(127.07) 119.47(126.44)
MVI present (n = 12) 355.35(899.73) 173.31(213.58) 94.63(90.02)
p 0.53a 0.17a 0.17a
Fuhrman’s Grade I e II (n = 32) 56.44(99.57) 103.91(158.18) 135.37(152.50)
Fuhrman’s Grade III e IV (n = 24) 169.48(557.25) 113.84(143.83) 101.01(92.55)
P 0.33a 0.83a 0.40a
pT1–2 (n = 26) 48.99(94.76) 67.86(60.49) 115.03(103.12)
pT3–4 (n = 30) 161.87(521.68) 143.33(187.99) 115.59(136.84)
P 0.33a 0.11a 0.98a
Metastasis Absent (n = 48) 119.99(0.47) 117.25(5.12) 109.83(122.37)
Metastasis Present (n = 8) 50.56(114.07) 54.21(43.87) 149.38(113.15)
p 0.66a 0.38a 0.50a
  1. aMann-Whitney test bAnova b Kruskall-Wallis Test
  2. significant p-value are highlighted in bold